Skip to main content
Fig. 1 | Diagnostic Pathology

Fig. 1

From: Increased expression of claudin-17 promotes a malignant phenotype in hepatocyte via Tyk2/Stat3 signaling and is associated with poor prognosis in patients with hepatocellular carcinoma

Fig. 1

The expression levels of CLDN17 in HCC cell lines and tissues. a The relative mRNA level of CLDN17 in the hepatocyte line and HCC cell lines; (b) The relative protein expression of CLDN17 in the hepatocyte line and HCC cell lines; (c) The corresponding statistical analysis of protein expression in the hepatocyte line and HCC cell lines; (d) The correlation between the expression of CLDN17 and survival in HCC patients; (e) The protein expression of CLDN17 in hepatocyte tissues, cirrhosis tissues, tissues adjacent to the tumors and HCC tissues. Note: * represents P < 0.05, ** represents P < 0.01, compared with the empty vector groups

Back to article page